Jane Street’s Xtant Medical Holdings XTNT Stock Holding History

Jane Street’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,978	Closed	-$19K	–	13349
2026 Q1	$19K	Buy	33,978 +14,772	+77%	+$9.09K	﹤0.01%	11200
2025 Q4	$15.1K	Buy	+19,206	New	+$14K	﹤0.01%	10777
2025 Q3	–	Sell	-35,782	Closed	-$26.4K	–	11919
2025 Q2	$26.4K	Buy	+35,782	New	+$20.3K	﹤0.01%	9316

Other funds holding XTNT

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jane Street's XTNT Position: Q2 2026 in Review

Jane Street sold out of Xtant Medical Holdings (XTNT) in Q2 2026, closing a stake of 33,978 shares — an estimated $19K sold.

Jane Street first reported a position in XTNT in Q2 2025 and held it in 3 quarters. The position peaked at $26.4K in Q2 2025. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

Jane Street reported no remaining Xtant Medical Holdings position as of Q2 2026 after selling out during the quarter.
Jane Street sold 33,978 Xtant Medical Holdings shares in Q2 2026, an estimated $19K.
Jane Street first reported a position in Xtant Medical Holdings in Q2 2025 and held it in 3 quarters.
Jane Street's Xtant Medical Holdings position peaked at $26.4K in Q2 2025.
32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.